Judge deems Trump’s National Institutes of Health grant cuts illegal

Published 06/16/2025, 02:35 PM
Updated 06/16/2025, 07:41 PM
© Reuters. The National Institutes of Health (NIH) Gateway Center is seen in the rain in Bethesda, Maryland, U.S., June 8, 2025. REUTERS/Elizabeth Frantz/File Photo

By Daniel Wiessner and Nate Raymond

BOSTON (Reuters) -A federal judge in Boston on Monday said the termination of National Institutes of Health grants for research on diversity-related topics by President Donald Trump’s administration was "void and illegal," and accused the government of discriminating against racial minorities and LGBT people.

U.S. District Judge William Young during a non-jury trial said the NIH violated federal law by arbitrarily canceling more than $1 billion in research grants because of their perceived connection to diversity, equity and inclusion initiatives.

Young said he was reinstating grants that had been awarded to organizations and Democratic-led states that sued over the terminations. And the judge indicated that as the case proceeds he could issue a more sweeping decision.     

"This represents racial discrimination and discrimination against America’s LGBTQ community," said Young, an appointee of Republican former President Ronald Reagan. "Any discrimination by our government is so wrong that it requires the court to enjoin it and at an appropriate time, I’m going to do it."

Referring to the termination of grants for research related to issues involving racial minorities, the judge said he had in four decades on the bench "never seen a record where racial discrimination was so palpable."

"You are bearing down on people of color because of their color," the judge said, referring to Trump’s administration. "The Constitution will not permit that."

Andrew Nixon, a spokesman for the U.S. Department of Health and Human Services, said the agency stands by its decision to end funding for research "that prioritized ideological agendas over scientific rigor and meaningful outcomes for the American people," and is considering an appeal.

"Under the leadership of Secretary Kennedy and the Trump administration, HHS is committed to ensuring that taxpayer dollars support programs rooted in evidence-based practices and gold standard science – not driven by divisive DEI mandates or gender ideology," Nixon said in a statement, referring to HHS Secretary Robert F. Kennedy Jr.

Rachel Meeropol of the American Civil Liberties Union, which represents the grant recipients who sued, said Young’s ruling applies to hundreds of grants. The plaintiffs include the American Public Health Association, a membership organization for public health researchers, and 16 states led by Massachusetts.

The NIH, the world’s leading funder of biomedical and behavioral research, has terminated 2,100 research grants totaling about $9.5 billion and an additional $2.6 billion in contracts since Trump took office in January, according to a letter that dozens of NIH employees signed last week, protesting the cuts.

The funding cuts are part of Trump’s wide-ranging actions to reshape the government, slash federal spending and end government support for DEI programs and transgender healthcare. The administration’s plans to cut 10,000 jobs at health agencies including NIH have been temporarily blocked by another federal judge.

Trump also has signed a series of executive orders requiring agencies to ensure grant funds do not promote "gender ideology" and to end support of what it sees as discriminatory DEI programs. Conservative critics of DEI programs have portrayed them as discriminatory against white people and certain others.

In line with Trump’s policy agenda, the NIH has instructed staff to terminate grant funding for studies related to DEI programs, transgender issues, COVID-19 and ways to curb vaccine hesitancy, and grants that could potentially benefit Chinese universities.

The trial that Young held on Monday concerned only some of the claims in the consolidated lawsuits over the cuts. The judge will consider others later.

Young said he would give the parties an opportunity to present further evidence before he rules on those claims and decides whether to reinstate grants beyond those awarded to the plaintiffs.

Massachusetts Governor Maura Healey in a statement said Young’s ruling was welcome, but that the NIH cuts had already halted crucial research into cures for disease including cancer and Alzheimer’s.

"He forced our research universities to lay off staff and rescind PhD offers. And he handed China and other foreign countries the opportunity to recruit away our researchers, scientists and entrepreneurs," said Healey, a Democrat.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.